Funding for this research was provided by:
Estate of J. Douglas Crashley (N/A)
Ontario Student Opportunity Trust Funds (N/A)
Canadian Blood Services (N/A)
Leukemia and Lymphoma Society of Canada
Novartis Pharmaceuticals Canada
Received: 12 September 2020
Accepted: 26 April 2021
First Online: 6 May 2021
: All experimental protocols were conducted with the approval of the Animal Care Committee of Sunnybrook Research Institute.
: Not applicable.
: The authors declare that they have no competing interests.